Eco Animal Health Group plc is engaged in the development, registration and marketing of pharmaceutical products for global animal health markets. The Company's principal activity is the manufacture and supply of animal health products across the globe. These activities are conducted on a global scale, through a network, including both regional offices (notably in Shanghai and Princeton) and overseas subsidiaries. The Company's products include Aivlosin and Ecomectin. Aivlosin is an antibiotic that treats a range of specific enteric (gut) and respiratory diseases in pigs and poultry. Ecomectin is an endectocide that controls worms, ticks, lice and mange in grazing stock and pigs. It operates in the United Kingdom and Europe, the Far East, Latin America, North America, and the Middle East and Africa. Its subsidiaries include Eco Animal Health Limited and ECO Animal Health do Brasil Comercio de Produtos Veterinarios Ltda.

Pharmaceutical

ECO Animal Health Group PLC

David Charles Hallas

David Hallas

The Finance and Control team at ECO Animal Health Group PLC is responsible for overseeing the company's financial operations and ensuring fiscal integrity. This includes managing financial reporting, compliance, budgeting, and financial planning across the company's global network. The team also supports strategic decision-making by providing financial insights and analyses, facilitating efficient resource allocation, and ensuring adherence to financial regulations and standards.

Finance and Control

About

Team members

Other teams at ECO Animal Health Group PLC

Sales And Marketing

Leadership Team